Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by kingposton Apr 22, 2015 10:40am
111 Views
Post# 23652297

RE:Teva makes $40 Billion ish bid for Mylan...today

RE:Teva makes $40 Billion ish bid for Mylan...todayA bit of an update on th Teva bid for Mylan:
-It is a hostile bid and Teva is making no effort to schmooz Mylan managemnt...apparently they are thinking shareholders will vote in favor of the bid with its 20% premium price to market price before the bid. 
-It looks like Mylan management is not in favor of selling. Speculation is that this is because certain Mylan management have been using the company as a "personal piggy bank" .... There is also the possibility they think they can do better long term by just growing the business organically..
-I would put a 30% chance of this deal going through, but this is just a guesstimate.
-BTW the Mylan CEO's dad is a US Senator...
Bullboard Posts